Colorectal cancer outcomes with an immunomodulator plus standard therapies

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study collects real-world data from colorectal cancer patients who did and did not receive an immunomodulator alongside standard anti-cancer therapies. It includes retrospective and prospective records to explore associations between immunomodulator use and clinical outcomes within the tumor microenvironment. The research aims to identify potential benefits and safety signals in routine care settings, without imposing a new treatment protocol. Data will be drawn from medical records at Cheng Ching General Hospital, Chung Kang Branch in Taichung, Taiwan, led by Chou-Chen Chen.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Aged 20 years and older
* Patients who have been given a diagnosis of colorectal cancer
* Patients had previously initiated anti-cancer therapies between Jan 01 2025 and Dec 31, 2027

Exclusion Criteria:

* Non

Where it's running

• Cheng Ching General Hospital, Chung Kang Branch
  Taichung, Taiwan Recruiting

Study contacts

• Study coordinator: Chou-Chen Chen
• Email: ccchen24615237@gmail.com

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Turnbull-Cutait versus low anterior resection to avoid a permanent stoma in low rectal cancer

  This study will try whether Turnbull-Cutait delayed coloanal anastomosis or low anterior resection with a protective stoma better keeps adults with low rectal cancer stoma-free over three years.

  Recruiting at 2 sites The First Hospital of Jilin University · Changchun, Jilin and 1 other locations · NCT07369531

• Moderately hypofractionated adaptive postoperative radiotherapy for high-risk endometrial cancer

  This study will test a shorter, adaptive postoperative radiation schedule for people with high-risk endometrial cancer to shorten treatment time while watching for side effects and cancer control.

  Recruiting Peking Union Medical College Hospital · Beijing, Beijing Municipality · NCT07116213

• Dose-adjusted EPOCH infusions for frail adults with acute lymphoblastic leukemia

  This project will see if a dose-adjusted, infusion-based EPOCH chemotherapy regimen helps frail adults with acute lymphoblastic leukemia tolerate treatment better and live longer.

  Recruiting Hospital General de Mexico · Mexico City, Mexico City · NCT07258043

• Comparing microwave ablation and liver surgery for treating intrahepatic cholangiocarcinoma

  This study is testing whether microwave ablation can be a good first treatment option for people with a specific type of liver cancer compared to traditional liver surgery.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT06462742

• New target method for treating high-grade glioma patients

  This study tests a new way of targeting radiation treatment for patients with high-grade glioma to see if it helps them live longer without their cancer getting worse and reduces side effects compared to the standard method.

  Recruiting Zhujiang Hospital · Guangzhou · NCT06215495

• Long-term follow-up for patients treated with CAR T cells

  This study looks at how well CAR T cell therapy works and its long-term safety for patients up to 15 years after their treatment.

  Recruiting Massachusetts General Hospital · Boston, Massachusetts · NCT05024175

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.